Repeat Organ Transplantation in the United States, 1996–2005 by Basadonna, G. P. et al.
American Journal of Transplantation 2007; 7 (Part 2): 1424–1433
Blackwell Munksgaard
No claim to original US government works
Journal compilation C© 2007 The American Society of
Transplantation and the American Society of Transplant Surgeons
doi: 10.1111/j.1600-6143.2007.01786.x
Repeat Organ Transplantation
in the United States, 1996–2005
J. C. Mageea,∗, M. L. Barrb, G. P. Basadonnac,
M. R. Johnsond, S. Mahadevana, M. A. McBridee,
D. E. Schaubela and A. B. Leichtmana
a Scientific Registry of Transplant Recipients/University of
Michigan, Ann Arbor, Michigan, USA
bUniversity of Southern California, Los Angeles,
California, USA
cUniversity of Massachusetts, Worcester,
Massachusetts, USA
dUniversity of Wisconsin-Madison, Madison, Wisconsin,
USA
eOrgan Procurement and Transplantation Network, United
Network for Organ Sharing, Richmond, Virginia, USA∗Corresponding author: John C. Magee,
mageej@med.umich.edu
The prospect of graft loss is a problem faced by all
transplant recipients, and retransplantation is often an
option when loss occurs. To assess current trends in
retransplantation, we analyzed data for retransplant
candidates and recipients over the last 10 years, as
well as current outcomes. During 2005, retransplant
candidates represented 13.5%, 7.9%, 4.1% and 5.5% of
all newly registered kidney, liver, heart and lung candi-
dates, respectively. At the end of 2005, candidates for
retransplantation accounted for 15.3% of kidney trans-
plant candidates, and lower proportions of liver (5.1%),
heart (5.3%) and lung (3.3%) candidates. Retransplants
represented 12.4% of kidney, 9.0% of liver, 4.7% of
heart and 5.3% of lung transplants performed in 2005.
The absolute number of retransplants has grown most
notably in kidney transplantation, increasing 40% over
the last 10 years; the relative growth of retransplan-
tation was most marked in heart and lung trans-
plantation, increasing 66% and 217%, respectively.
The growth of liver retransplantation was only 11%.
Unadjusted graft survival remains significantly lower
after retransplantation in the most recent cohorts
analyzed. Even with careful case mix adjustments,
the risk of graft failure following retransplantation is
significantly higher than that observed for primary
transplants.
Key words: Candidates, graft loss, graft survival,
OPTN, retransplantation, SRTR, waiting list
Introduction
Transplantation is often the best option for patients faced
with organ failure. However, while outcomes following
transplantation have improved over the years, allograft loss
is a problem ultimately confronted by many recipients.
For such patients, repeat transplantation often provides
the best chance for survival and good health. While re-
transplantation offers hope, previous studies have demon-
strated that outcomes following repeat transplantation are,
in general, inferior to those observed with first transplants
(1–8). Since every organ used for repeat transplantation
represents an opportunity that cannot be directed to an-
other candidate, the potentially expanding role of retrans-
plantation has been of growing concern to the transplant
community.
While there have been multiple single center reports focus-
ing on repeat transplantation, the overall effect of retrans-
plantation across solid organ transplantation in the United
States has not been evaluated in a comprehensive manner.
Listing practices, access to transplantation and outcomes
of repeat transplantation are largely unstudied. We provide
here a broad overview and selected summary data on the
current state of repeat kidney, liver, heart and lung trans-
plantation, specifically focusing on trends among retrans-
plant candidates and recipients.
Methods
For the purpose of this analysis, unless otherwise noted, repeat transplanta-
tion (also referred to as retransplantation) includes only candidates or recip-
ients of a second or subsequent organ transplant of the same type, rather
than a sequential transplant of a different organ type. For example, an extra-
renal transplant recipient who developed end-stage renal disease (ESRD)
following transplant and then underwent kidney transplantation would not
be counted as a repeat transplant recipient on the basis of that kidney trans-
plant procedure.
Descriptive data and analysis regarding registrants and recipients were pro-
vided by the Organ Procurement and Transplantation Network (OPTN) and
are current as of December 31, 2005. Outcomes following retransplantation
were analyzed using the Scientific Registry of Transplant Recipients (SRTR)
database. This data set combines OPTN data with information from the So-
cial Security Death Master File (SSDMF) and the Centers for Medicare and
Medicaid Services (CMS). The SSDMF provides extra ascertainment regard-
ing recipient mortality, while the CMS data provide additional information
regarding kidney allograft failure.
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Unadjusted graft survival rates for first transplants and retransplants per-
formed from January 1, 2000, to December 31, 2005, were calculated using
the Kaplan-Meier method. Adjusted graft survival was calculated using Cox
proportional hazard models, following the methodology employed in SRTR
center-specific reports (9). Separate models were developed for each organ
transplant investigated. The following cohorts were used: kidney and liver
1-year graft survival—January 1, 2003, to June 30, 2005; kidney and liver
3-year graft survival—July 1, 2000, to December 31, 2002; heart and lung
1-year graft survival—July 1, 2002, to December 31, 2004, and heart and
lung 3-year graft survival—July 1, 2000, to December 31, 2002. Cohorts
were analyzed independently to determine the relative risks of graft failure
at 1 and 3 years following transplantation. Except in the case of heart trans-
plantation, the adjustments remained constant between the 1- and 3-year
cohorts, as detailed below.
In the analysis examining the risk of graft loss following kidney transplan-
tation, adjustments were made for recipient age, race, body mass index,
diagnosis, functional status, insurance type, peak panel reactive antibody
(PRA), length of ESRD treatment and level of human leukocyte antigen
mismatch. In the living donor kidney transplant analysis, the relationship
between the donor and recipient and donor age and race were included in
the model. The model for deceased donor kidney transplantation included
donor age, race, cause of death, diabetes, hypertension, creatinine, dona-
tion after cardiac death (DCD), cold ischemia time (CIT), pumping, sharing
outside of the recovering donation service area (DSA) and donor-to-recipient
weight ratio.
Analyses of repeat liver transplantation are of deceased donor transplants,
as the use of living donor livers for retransplant candidates was infrequent
enough to preclude meaningful analysis. The liver transplant models in-
cluded adjustments for recipient age, race, diagnosis, medical condition,
ascites, creatinine, diabetes, life support, inotropes used for blood pressure
support and previous abdominal surgery. Donor factors included donor age,
race, cause of death and DCD. The use of shared organs outside the DSA,
partial or split liver and ABO blood-type compatibility were also accounted
for in this model.
In the analysis of heart transplantation, the model for the 1-year cohort
included recipient age, diagnosis, medical condition, creatinine, ventilator
status, use of extracorporeal membrane oxygenation, donor age, cause
of death and CIT. The model for the 3-year cohort adjusted for recipient,
age, race, sex, height, weight, diagnosis, ventilator status, diabetes, creati-
nine, intra-aortic balloon pumping, Status 1A, donor age, cause of death and
CIT.
The lung transplant model was adjusted for recipient factors including age,
race, sex, diagnosis, functional status, cardiac index, forced vital capacity
and ventilator use. Donor factors included age, race, cause of death, dia-
betes and body surface area.
The population was restricted to adult recipients (age 18 years or greater)
for kidney, liver and heart recipients. In light of recent changes in the OPTN
lung allocation policy, children aged 12 years or older were included in the
lung recipient models.
Results
Impact of retransplantation on waiting lists
and transplant activity
The percentage of candidates on the OPTN waiting list who
are waiting for repeat transplantation varies by organ. On
Source: OPTN Analysis, February 2006.
Figure 1: Percentage of all registrants listed for a second,
third, or fourth transplant at end of 2005, by organ type.
December 31, 2005, 16.1% of kidney, 3.4% of liver, 3.2%
of heart and 2.1% of lung registrants were wait-listed for
repeat transplantation. The majority of these candidates
were wait-listed for a second transplant (Figure 1). Reg-
istration for a third transplant was most common among
kidney transplant recipients, followed by liver recipients.
Registration for a second or subsequent transplant was
rare among heart and lung recipients.
Across all organs, candidates awaiting retransplantation
are notably younger than registrants on the overall wait-
ing list (Figure 2). In the case of kidney transplantation,
greater than 20% of registrants less than 49 years of age
and 12.1% between 50 and 64 years were registered for
a second or subsequent kidney transplant.
Over the last 10 years, the yearly percentage of new
kidney, heart and lung waiting list registrants who were
candidates for retransplantation has remained relatively
stable (Figure 3). In contrast, the percentage of new
registrations for liver retransplantation has been falling
gradually, from 7.9% in 1996 to 5.1% in 2005. This
Source: OPTN Analysis, February 2006.
Figure 2: Percentage of registrants in each age group listed
for a repeat transplant at end of 2005, by organ type and can-
didate age.
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Source: OPTN Analysis, November 2006.
Figure 3: Percentage of all new registrants added to the wait-
ing list for a repeat transplant, by organ type,1996–2005.
modest decrease may reflect multiple factors, including
identification of more suitable candidates for primary trans-
plantation, fewer previous liver transplant recipients be-
ing accepted for retransplantation and better selection of
donor livers leading to a lower rate of graft failure.
Since 1996, there has been a steady increase in the number
of kidney retransplant recipients (Figure 4). Despite small
increments in retransplant activity in 2005, similar trends
are not observed in liver, heart and lung transplantation.
Kidney retransplantation
Over the course of the decade, the percentage of new kid-
ney transplant registrants each year who were retransplant
candidates remained relatively constant (Figure 5). In 2005,
13.5% of all new kidney registrants represented retrans-
plants. The percentage of retransplant registrants on the
waiting list at year-end decreased slowly, from 17.2% in
1996 to 15.3% in 2005. Among new registrations, the rel-
ative contribution from retransplant registrants was high-
est in the 18–49-year age group (Figure 6). However, the
Includes Living and Deceased Donors
Source: OPTN Analysis, February 2006.
Figure 4: Number of repeat transplants, by organ, 1996–2005.
Source: OPTN Analysis, November 2006.
Figure 5: Percentage of all new registrants added to the wait-
ing list for repeat kidney transplantation and percentage on
waiting list at year-end, 1996–2005.
percentage of new registrants within this age group has
fallen, from 10.5% in 1996 to 8.5% in 2005.
In 2005, 664 (10.9%) of living donor and 1182 (13.6%)
of deceased donor kidney transplants were retransplants.
The relative percentages have changed little over the
decade. In 1996, the percentage of living donor transplants
represented by retransplantation was 8.9%, while the per-
centage of deceased donor transplants represented by re-
transplantation was 14.4%. When stratified by recipient
age, patients in the 18–49-year age group represented the
greatest percentage of retransplant recipients (Figure 7).
Retransplant recipients tend to have been on the wait-
ing list slightly longer compared with primary recipients
(Figure 8). Importantly, this figure does not reflect the fate
of some retransplant candidates who continue to remain
on the waiting list and never receive another transplant.
At least one significant factor contributing to the difficulty
finding suitable grafts for retransplant candidates is allosen-
sitization. Retransplant recipients have a higher PRA at list-
ing compared with primary recipients, with 31.5% having
a PRA of 20% or higher at the time of listing (Figure 9).
For the majority of second kidney transplants performed in
2005, the interval between the primary kidney transplant
and retransplantation was greater than 5 years, with the
largest fraction retransplanted more than 10 years after
their first transplant procedure (Figure 10). Of candidates
who undergo repeat kidney transplantation, the etiology
of their initial graft loss varies, depending on when the
graft is lost. For patients who lose their primary graft within
the first year after transplantation, acute rejection and graft
thrombosis are reported as the cause of graft failure in
more than half the cases. For primary graft loss occurring
more than 1 year posttransplant, chronic rejection accounts
for nearly two thirds of the graft loss. In both recipient
cohorts, recurrent disease accounts for less than 10% of
all primary graft failures.
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Outcomes following repeat kidney transplantation: Of
the 35 340 living donor kidney transplants performed be-
tween 2000 and 2005, 7.1% were repeat transplants. The
unadjusted 1-, 3- and 5-year graft survival rates for repeat
living donor transplants (93%, 83% and 76%), were all sig-
nificantly lower than observed for first living donor trans-
plants (95%, 89% and 81%, respectively) (p < 0.01, p <
0.0001, p = 0.01, respectively) (Figure 11). During the same
period, of the 48 351 deceased donor kidney transplants
performed, 9.7% were retransplants. A similar trend in dif-
ferences in unadjusted survival between first and repeat
transplants was observed. The unadjusted 1-, 3- and 5-year
graft survival for repeat deceased donor transplants (87%,
76% and 63%) were all significantly lower than observed
for first deceased donor transplants (90%, 79% and 68%,
respectively) (all p < 0.002) (Figure 11). Interestingly, out-
comes for recipients of living donor retransplants remain
better than those observed after primary deceased donor
transplants. After adjusting for donor and recipient factors,
the relative risks of graft failure for living donor kidney trans-
plants following repeat kidney transplantation was 0.96
(p = 0.7886) at 1 year and 1.33 (p = 0.0005) at 3 years.
For deceased donor kidney transplants, the relative risk
was 1.18 (p = 0.0236) and 1.24 (p = 0.0001) at 1 and
3 years, respectively.
Liver retransplantation
Over the last 10 years, the percentage of new liver trans-
plant registrants who were retransplant candidates de-
creased slightly, from 9.3% in 1996 to a nadir of 6.7%
in 2004, with a rebound to 7.9% in 2005 (Figure 12). The
percentage of retransplant registrants on the waiting list
at year-end had a similar decline over the same period.
At year-end in 2005, retransplant registrations represented
5.1% of all candidates.
Of the new registrations, over the last 10 years, the pro-
portion of recipients in the 18–49-year age group regis-
tered for retransplantation decreased from 4.6% in 1996
to 2.7% in 2005, while registrations for retransplantation in-
creased from 2.7% in 1996 to 3.6% in 2005 for candidates
Source: OPTN Analysis, November 2006.
Figure 6: Percentage of all new registrants added to the wait-
ing list for repeat kidney transplantation, by age, 1996–2005.
Source: OPTN Analysis, February 2006.
Figure 7: Percentage of repeat kidney transplants, by recipi-
ent age, 1996–2005.
in the 50–64-year age range. The proportion was stable
at less than 1% for candidates greater than age 65 years
(Figure 13).
With respect to transplantation, the percentage of all liver
transplants that were retransplants decreased from a peak
of 11.5% in 1997 to 9.0% in 2005. When stratified by recip-
ient age, recipients in the 18–49-year range demonstrated
a decline in the percentage of retransplants from a high
of 6.1 in 1997 to 3.0 in 2005, whereas the percentage of
liver transplants that were retransplants for the age group
50–64 years remained stable between 3% and 4%. The
percentage remained below 1% for those greater than age
65 years (Figure 14).
Of candidates who undergo repeat liver transplantation,
the etiology of their initial graft loss varies, depending on
when the graft is lost. For candidates who lose their pri-
mary graft in the first year, primary nonfunction and vas-
cular thrombosis account for over 70% of the causes of
graft failure leading to retransplant (Figure 15). For recipi-
ents retransplanted more than 1 year after transplantation,
Source: OPTN Analysis, November 2006.
Figure 8: Deceased donor kidney transplants in 2005, by time
on waiting list.
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Source: OPTN Analysis, November 2006.
Figure 9: Deceased donor kidney transplants in 2005, by peak
PRA at listing.
chronic rejection and recurrent hepatitis account for greater
than half of the cases (Figure 16). Evaluation of time from
first transplant to retransplant reflects these issues as well.
There is a highly skewed distribution with the highest rate
of graft loss occurring within the first week, and the major-
ity of graft loss within the first year following transplanta-
tion (Figure 17).
While it is not surprising that a greater fraction of retrans-
plant recipients, compared with primary transplant recipi-
ents, are listed as Status 1, it is interesting to note that,
compared with primary transplant recipients, the retrans-
plant population has a Model for End-stage Liver Disease
(MELD) score distribution at transplant that is higher than
that seen for primary liver recipients (Figure 18).
Outcomes following repeat liver transplantation: Of
the 29 283 deceased donor liver transplants performed be-
tween 2000 and 2005, 8.1% were retransplants. The un-
adjusted 1-, 3- and 5-year graft survival rates for repeat
Source: OPTN Analysis, February 2006.
Figure 10: Time from first kidney transplant to repeat trans-
plant, for retransplanted recipients in 2005.
Source: SRTR Analysis, May 2006.
Figure 11: Unadjusted living donor (LD) and deceased donor
(DD) graft survival for first and second kidney transplants,
2000–2005.
deceased donor transplants (67%, 60% and 53%), were
all significantly lower than those observed following first
deceased donor transplants (83%,75% and 69%) (all p <
0.0001) (Figure 19). Compared with first transplants, after
adjusting for donor and recipient factors, the relative risk of
graft loss for retransplants was 1.59 (p < 0.0001) at 1 year
and 1.60 (p < 0.0001) at 3 years following retransplanta-
tion.
Heart retransplantation
Over the last 10 years, the percentage of new heart trans-
plant registrants for repeat heart transplantation was stable
from 1996 to 2004, then rose from 3.4% in 2004 to 4.1%
in 2005 (Figure 20). The percentage of retransplant regis-
trants on the waiting list at year-end increased in a similar
pattern and by a similar magnitude. At year-end in 2005, re-
transplant registrations represented 5.3% of all candidates.
Of the new registrations, the relative contributions from
recipients aged less than 18 years, 18–49 years and 50–64
Source: OPTN Analysis, November 2006.
Figure 12: Percentage of all new registrants added to the
waiting list for repeat liver transplantation and percentage
on waiting list at year-end, 1996–2005.
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Source: OPTN Analysis, November 2006.
Figure 13: Percentage of all new registrants added to the
waiting list for repeat liver transplantation, by recipient age,
1996–2005.
years were similar in 2005. Registration for retransplanta-
tion in the 65-year and older age range was uncommon
(Figure 21).
Overall, the percentage of all heart transplants that are re-
transplants increased over the decade from 2.6% in 1996
to 4.7% in 2005. When stratified by age, recipients less
than 65 years old contributed relatively equally in 2005 to
the percentage representing heart retransplantation (Fig-
ure 22). Retransplantation was rare in recipients aged 65
years or greater.
Outcomes following repeat heart transplantation: Be-
tween 2000 and 2005, there were 364 heart retransplants,
which accounted for 2.9% of all heart transplants. As seen
with kidney and liver transplants, the 1-, 3- and 5-year un-
adjusted graft survival rates for heart retransplants (82%,
70% and 58%) were all, respectively, lower than those for
first heart transplants (86%, 80% and 73%; all p < 0.0001)
(Figure 23). After adjusting for donor and recipient factors,
the relative risk for graft loss after retransplantation com-
pared with first heart transplantation was 1.34 (p = 0.1514)
Source: OPTN Analysis, February 2006.
Figure 14: Percentage of repeat liver transplants, by recipient
age, 1996–2005.
Includes transplants Since October 1, 1987
Source: OPTN Analysis, February 2006.
Figure 15: Causes of primary graft failure for liver transplant
recipients retransplanted less than 1 year post-primary trans-
plant.
at 1 year and 1.16 (p = 0.4263) at 3 years after transplan-
tation.
Lung retransplantation
The percentage of new lung transplant registrants who
were retransplant candidates was stable between 1996
and 2003, but then increased from 2.9% in 2003 to 5.5%
in 2005 (Figure 24). The percentage of retransplant regis-
trants on the waiting list at year-end declined over the last
10 years, from 4.2% in 1996 to a low of 2.6% in 2003,
increasing slightly to 3.3% in 2005.
Of the new registrations, candidates aged 18–49 years ac-
counted for the largest age group, though the last 2 years
have witnessed an increase in the 50–64-year age group
registered for retransplantation (Figure 25).
Overall, the percentage of all lung transplants that are re-
transplants increased over the decade, from 2.8% in 1996
to 5.3% in 2005. When stratified by recipient age, recip-
ients in the 18–49-year age range had the greatest per-
centage of retransplants, though the percentage in the
Includes transplants Since October 1, 1987
Source: OPTN Analysis, February 2006.
Figure 16: Causes of primary graft failure for liver trans-
plant recipients retransplanted more than 1 year post-primary
transplant.
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Source: OPTN Analysis, February 2006.
Figure 17: Time from first liver transplant to repeat transplan-
tation for retransplanted recipients in 2005.
50–64-year age range has grown remarkably since 2004.
In 2005, the figures in both these cohorts were equivalent
(Figure 26).
Outcomes following repeat lung transplantation: Of
the 6616 deceased donor lung transplants performed be-
tween 2000 and 2005 in recipients aged 12 years and older,
3.1% were repeat transplants. The unadjusted 1-, 3- and
5-year graft survivals for repeat deceased donor lung trans-
plants (55%, 36% and 22%) were significantly lower than
those for first transplants (81%, 65% and 50%; all p <
0.0001) (Figure 27). After adjusting for donor and recipient
factors, the relative risks of graft failure at 1 and 3 years for
deceased donor lung retransplants were 2.13 (p = 0.0006)
and 1.82 (p = 0.0016), respectively.
Discussion
Candidates for repeat transplantation are a sizeable and
stable percentage (15.3%) of the kidney transplant waiting
list. For the heart, lung and liver transplant waiting lists, can-
Source: OPTN Analysis, November 2006.
Figure 18: Repeat liver transplants in 2005, by status or
MELD/PELD score at transplantation.
Source: SRTR Analysis, May 2006.
Figure 19: Unadjusted deceased donor graft survival for first
and second liver transplants, 2000–2005.
didates for retransplant make up 5% or less, a still impor-
tant fraction. It appears over the last 10 years that there has
been a decrease in the portion of the liver transplant waiting
list that comprises candidates for repeat transplantation.
For all organs, except kidney, virtually all of the candidates
for repeat transplantation are waiting for a second trans-
plant. In contrast, somewhat greater than 2% of the kidney
transplant waiting list is registered for a third or subsequent
transplant. The majority of candidates for repeat transplan-
tation are less than 50 years of age. The absolute number of
repeat transplants has grown, most notably among recipi-
ents of kidney transplants. Over the last 10 years, the num-
ber of repeat kidney transplants has increased 40%, with
1846 repeat kidney transplants in 2005. The numbers of
repeat liver, heart and lung transplants are smaller by com-
parison. Interestingly, the growth of retransplantation for
livers was only 11%, while heart and lung increased 66%
and 217%, respectively. Repeat transplantation represents
12.4% of kidney (10.9% of all living donor and 13.6% of
all deceased donor kidney transplants), 9.0% of liver, 4.7%
of heart and 5.3% of lung transplants performed in 2005.
Most repeat kidney transplants are performed more than 5
years following the original transplant. However, the great
Source: OPTN Analysis, November 2006.
Figure 20: Percentage of all new registrants added to the
waiting list for repeat heart transplant and percentage on
waiting list at year-end, 1996–2005.
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Source: OPTN Analysis, November 2006.
Figure 21: Percentage of all new registrants added to the
waiting list for a repeat heart transplant, by age, 1996–2005.
majority of repeat liver transplants are performed less than
5 years following primary liver transplant, and the high-
est rates are seen in the earlier post-transplant periods.
Even with careful case mix adjustments, allograft survival
is good, but significantly less, among recipients of repeat
kidney, liver and heart transplants compared with the sur-
vival obtained from primary transplantation. Unfortunately,
recipients of repeat lung transplants achieve only 22.4%
5-year allograft survival, or about half of what is obtained
for recipients of primary lung allografts.
On a yearly percentage basis, repeat transplantation rep-
resents a stable fraction of the kidney candidate and
recipient pools, and results are generally accepted as
adequate. However, the total number of repeat kidney
transplants is increasing, and, as a consequence of the
availability of dialysis to serve as a bridge to repeat trans-
plantation, the total number of repeat kidney transplants
is likely to grow. Additionally, because candidates awaiting
kidney retransplantation are frequently allosensitized, they
are often less likely to receive a transplant than primary kid-
Source: OPTN Analysis, February 2006.
Figure 22: Percentage of repeat heart transplants, by recipi-
ent age, 1996–2005.
Source: SRTR Analysis, May 2006.
Figure 23: Unadjusted graft survival for first and second heart
transplants, 2000–2005.
ney candidates. Ongoing efforts at many centers involving
‘desensitization’ protocols for such individuals highlight the
pressing need in this patient population. Nonimmunologic
interventions, such as broader sharing of deceased donor
organs for highly sensitized recipients or the implemen-
tation of paired exchange programs for living donors may
offer additional options for allosensitized candidates.
In liver transplantation, the percentage of the waiting list
that is identified for repeat transplantation is falling. This
relative decline of repeat liver transplant registrants may
reflect the substantial increase in candidates for primary
transplantation, a higher threshold or greater reluctance to
list recipients for retransplantation, better organ selection
at primary transplantation or better management following
transplantation. Of particular interest in liver transplantation
is the impact of the primary diagnosis on outcomes follow-
ing retransplantation. Though not a focus of this analysis,
there is growing concern regarding the detrimental effect
of recurrent hepatitis C on outcomes following liver retrans-
plantation. In a recent SRTR analysis of adult liver recipients
who were retransplanted between 1997 and 2002, hepati-
tis C was the leading primary cause of liver disease (27%)
Source: OPTN Analysis, November 2006.
Figure 24: Percentage of all new registrants added to the
waiting list for repeat lung transplantation and percentage
on waiting list at year-end, 1996–2005.
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Source: OPTN Analysis, November 2006.
Figure 25: Percentage of all new registrants added to the
waiting list for repeat lung transplantation, by age, 1996–
2005.
(10). In this analysis, these recipients had a 30% higher
covariate-adjusted risk of mortality than those without hep-
atitis C. While hepatitis C was shown to be associated with
poorer outcomes, it is clear that many donor and recipi-
ent factors also contribute to the results, and attention to
these factors may improve outcomes. Whether or not the
small increase in the percentage of new registrants for re-
transplantation in 2005 signifies a new trend remains to be
determined.
Also of interest in liver transplantation is whether MELD
accurately reflects the risk of waiting list mortality for re-
transplant candidates compared with primary transplant
candidates. Since MELD forms the basis for allocation, any
disparity between the two groups would indicate differen-
tial access to transplantation. In an analysis of the OPTN
data set, Edwards and Harper demonstrated that while
MELD correlated with pretransplant mortality for both pri-
mary and retransplant liver candidates, there was better
concordance with waiting list mortality for primary candi-
dates compared with retransplant candidates (11). Addi-
tionally, it appeared that at MELD scores above 20, the
Source: OPTN Analysis, February 2006.
Figure 26: Percentage of repeat lung transplants, by recipient
age, 1996–2005.
Source: SRTR Analysis, May 2006.
Figure 27: Unadjusted deceased donor graft survival for first
and second lung transplants, 2000–2005.
risk of waiting list mortality at a given MELD score was
higher for retransplant candidates. Further analysis of this
finding is warranted.
Although the percentage of registrants for and recipients
of heart retransplantation have remained relatively stable
for the past 10 years, it will be important to determine
if the increases seen in 2005 represent variability or the
beginning of an upward trend. As survival following re-
peat heart transplant is less than that following primary
transplant, it will be important to further analyze the cur-
rent SRTR database to define risk factors for poor outcome
following retransplantation. Indeed, a previous analysis of
the Joint International Society for Heart and Lung Trans-
plantation (ISHLT)/United Network for Organ Sharing Tho-
racic Registry suggested that an inter-transplant interval of
less than 2 years resulted in decreased survival following
retransplantation (3). Furthermore, an analysis of data in
the Cardiac Transplant Research Database showed that an
inter-transplant interval of less than 6 months and retrans-
plantation for acute rejection or early graft failure resulted
in poor outcome (12). With the ongoing donor shortage
and the increased number of heart transplant recipients at
risk for allograft failure, predictors of poor outcome follow-
ing retransplantation need to be more clearly defined and
considered in selecting appropriate candidates to list for
retransplantation.
In lung transplantation, the percentage of registrants for
and recipients of lung retransplantation also have remained
relatively stable since 1996; it remains to be determined if
the increase in retransplant activity over the last year marks
the start of a distinct trend. Survival following lung retrans-
plantation is currently discouraging. Similar to the findings
of this current analysis, in the most recent report of the
ISHLT registry, using multivariate logistic regression, adult
lung retransplant recipients were shown to have a 2.12 rel-
ative risk of death at 1 year following transplantation com-
pared with primary lung recipients (13). In this analysis, the
risk of being a repeat transplant recipient was only second
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to a recipient diagnosis of primary pulmonary hypertension
as having the highest relative risk of 1-year mortality. This
significant impact of repeat transplantation was sustained
when looking at risk factors for 5-year mortality, where the
relative risk was 1.72. In this cohort, the risk factor of being
a repeat transplant recipient was only second to a recipi-
ent being on pre-operative intravenous inotropes as having
the highest relative risk of 5-year mortality. The marked im-
pact of retransplantation on patient survival was observed
in pediatric lung recipients, as well in the ISHLT Registry
(14). At 1 year following transplantation, the actuarial sur-
vival was 50% in the retransplantation group versus 80% in
the primary transplant group. The separation in the Kaplan-
Meier survival curves occurred immediately after the trans-
plant event and was most marked during the first year after
transplant, with a similar slope in the curves thereafter. This
suggests that the dramatic difference in survival during the
first year accounted for much of this difference.
This article has focused on the abdominal organs account-
ing for the greatest number of retransplants. It is worthy
to note that although there were only 90 pancreas retrans-
plants performed in 2005, this accounted for the highest
percentage of any organ being retransplanted (16.6% of
pancreas transplants were retransplants). Similarly, while
there were only 18 intestine retransplants performed in
2005, this represented 10.1% of all intestine transplants.
Further analysis of these observations is warranted.
Retransplantation offers hope for transplant recipients who
have had a graft fail. Unfortunately such failures, in ad-
dition to the suffering they place on the recipient, con-
tribute to the overall demand for organs. Given the short-
age of donor organs, retransplantation can create tension,
especially when outcomes following retransplantation are
below those observed for primary recipients. Absent elim-
inating primary graft failure or an infinite availability of
donor organs, finding an acceptable balance among these
competing issues is likely to be a continuing concern for
the transplant community. Reflecting these concerns, the
American Society of Transplant Surgeons, the American
Society of Transplantation and the National Institute of Al-
lergy and Infectious Diseases recently sponsored a confer-
ence focusing on the issue of retransplantation in March
2006. The organizers are summarizing much of the data
presented and formulating recommendations for publica-
tion in organ-specific manuscripts. The overarching conclu-
sion reached, however, was the pressing need for more
in-depth investigation regarding all facets of retransplanta-
tion.
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